Insufficient sensitivity of hemoglobin A1C determination in diagnosis or screening of early diabetic states

Metabolism: Clinical and Experimental

Volumn 60, Issue 1, 2011, Pages 86-91

  Fajans, Stefan S ^a   Herman, William H ^a   Oral, Elif A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; REFERENCE VALUE; RELIABILITY; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 78649906758     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.06.017     Document Type: Article

References (23)

1. International Expert Committee International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes Diabetes Care 32 2009 1327 1334
2. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 20 1997 1183 1197
3. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus 1999 World Health Org Geneva
4. Herman W.H. Diabetes epidemiology: guiding clinical and public health practice: the Kelly West Award lecture Diabetes Care 30 2006 1912 1919
5. Mohan V., Vijayachandrika V., and Gokulakrishnan K. A1C cut points to define various glucose intolerance groups in Asian Indians Diabetes Care 33 2010 515 519
6. Cowie C.C., Rust K.F., and Byrd-Holt D.D. Prevalence of diabetes and high risk for diabetes using hemoglobin A1c criteria in the U.S. population in 1988-2006 Diabetes Care 33 2010 562 568
7. Christensen D.L., Witte D.R., and Kaduka L. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups Diabetes Care 33 2010 580 582
8. Engelgau M.M., Thompson T.J., and Herman W.H. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited Diabetes Care 20 1997 785 791
9. Saudek C.D., Herman W.H., and Sacks D.B. A new look at screening and diagnosing diabetes mellitus J Clin Endocrinol Metab 93 2008 2447 2453
10. Moses R.G., and Cheung N.W. Point/counterpoint: point: universal screening for gestational diabetes mellitus Diabetes Care 32 2009 1349 1351
11. Berger H., and Sermer M. Point/counterpoint: counterpoint: selective screening for gestational diabetes mellitus Diabetes Care 32 2009 1352 1354
12. Tuomilehto J., Lindström J., Eriksson J.G. Finnish Diabetes Prevention Study Group Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 2001 1343 1350
13. Knowler W.C., Barrett-Connor E., Fowler S. The Diabetes Prevention Program Research Group Reduction in incidence of type 2 diabetes with life-style intervention or metformin N Engl J Med 346 2002 393 403
14. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
15. Buchanan T.A., Xiang A.H., and Peters R.K. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women Diabetes 51 2002 2796 2803
16. DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein H.C., Yusuf S., Bosch J., Pogue J., Sheridan P., Dinccag N., Hanefeld M., Hoogwerf B., Laakso M., Mohan V., Shaw J., Zinman B., and Holman R.R. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial Lancet 23 2006 1096 1105
17. Buell C., Kermah D., and Davidson M.B. Utility of A1C for diabetes screening in the 1999-2004 NHANES population Diabetes Care 30 2007 2233 2235
18. Inoue K., Matsumoto M., and Kobayashi Y. The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers Diabetes Res Clin Pract 77 2007 451 458
19. American Diabetes Association Standards of Medical Care in Diabetes-2010 Diabetes Care 33 Supp 1 2010 S11 S61
20. van't Riet E., Alssema M., Rijkelijkhuizen J.M., Kostense P.J., Nijpels G., and Dekker J.M. Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study Diabetes Care 33 2010 61 66
21. Abdul-Ghani M.A., Stern M.P., and Lyssenko V. Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose Diabetes Care 33 2010 557 561
22. Herman W.H., Ma Y., Uwaifo G. Diabetes Prevention Program Research Group Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program Diabetes Care 30 2007 2453 2457
23. Herman W.H., and Cohen R.M. Hemoglobin A1c: teaching a new dog old tricks Ann Int Med 152 2010 (in press, June 2010)